The pharmaceutical company Janssen of Johnson & Johnson began phase 3 trials of its vaccine against COVID-19, Foreign Minister Marcelo Ebrard announced this Saturday. “I congratulate the Janssen company that began phase 3 of its vaccine project in Mexico.
Welcome and we wish them the best of success in their work,” he posted on his Twitter account. With this, there are already two trials of this type being carried out in Mexico, along with that of the pharmaceutical company CanSino Biologics.
Hugo López-Gatell, Undersecretary of Health, announced in September that Janssen was seeking to carry out a trial of this type in our country for which 5,000 volunteers would be recruited throughout the country .
How would this test be done?
In that month, Janssen explained that during the study, staff will collect blood, saliva and nasal swabs from the participants. The test consists of two stages for each age group: the first group with people between 18 and 59 years old and who do not have other health conditions.
The second group includes people aged 60 and over. If participants do not qualify for the first group due to other health conditions, they can still qualify for the other.
Janssen further noted that if a volunteer becomes ill with COVID-19 (they cannot get it from the vaccine itself), they will be monitored daily by authorized company personnel and asked to provide additional saliva samples and nasal swabs.